Paramyxoviridae

Fields Virology: Sixth Edition

Volumn 1, Issue , 2013, Pages

  Lamb, Robert A ^a   Parks, Griffith D ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84974668337     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (457)

1. Alkhatib G, Richardson C, Shen SH. Intracellular processing, glycosylation, and cell-surface expression of the measles virus fusion protein (F) encoded by a recombinant adenovirus. Virology 1990;175:262-270.
2. Anderson K, King AM, Lerch RA, et al. Polylactosaminoglycan modification of the respiratory syncytial virus small hydrophobic (SH) protein: a conserved feature among human and bovine respiratory syncytial viruses. Virology 1992;191:417-430.
3. Andrejeva J, Childs KS, Young DF, et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci U S A 2004;101:17264-17269.
4. Andrejeva J, Poole E, Young DF, et al. The p127 subunit (DDB1) of the UV-DNA damage repair binding protein is essential for the targeted degradation of STAT1 by the V protein of the paramyxovirus SV5. J Virol 2002;76:11379-11386.
5. Arimilli S, Johnson JB, Alexander-Miller MA, et al. TLR-4 and -6 agonists reverse apoptosis and promote maturation of simian virus 5-infected human dendritic cells through NFκB-dependent pathways. Virology 2007;365:144-156.
6. Atreya PL, Peeples ME, Collins PL. The NS1 protein of human respiratory syncytial virus is a potent inhibitor of minigenome transcription and RNA replication. J Virol 1998;72:1452-1461.
7. Bachi T. Intramembrane structural differentiation in Sendai virus maturation. Virology 1980;106:41-49.
8. Bagai S, Lamb RA. Individual roles of N-linked oligosaccharide chains in intracellular transport of the paramyxovirus SV5 fusion protein. Virology 1995;209:250-256.
9. Baker KA, Dutch RE, Lamb RA, et al. Structural basis for paramyxovirus-mediated membrane fusion. Mol Cell 1999;3:309-319.
10. Bankamp B, Wilson J, Bellini WJ, et al. Identification of naturally occurring amino acid variations that affect the ability of the measles virus C protein to regulate genome replication and transcription. Virology 2005;336:120-129.
11. Baron MD, Barrett T. Rescue of rinderpest virus from cloned cDNA. J Virol 1997;71:1265-1271.
12. Baron MD, Barrett T. Rinderpest viruses lacking the C and V proteins show specific defects in growth and transcription of viral RNAs. J Virol 2000;74:2603-2611.
13. Bellini WJ, Englund G, Rozenblatt S, et al. Measles virus P gene codes for two proteins. J Virol 1985;53:908-919.
14. Bermingham A, Collins PL. The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription. Proc Natl Acad Sci U S A 1999;96:11259-11264.
15. Bhella D, Ralph A, Murphy LB, et al. Significant differences in nucleocapsid morphology within the Paramyxoviridae. J Gen Virol 2002;83:1831-1839.
16. Biron CA, Sen GC. Innate responses to viral infection. In: Knipe DM, Howley PM, eds. Fields Virology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2005:249-278.
17. Blanchard L, Tarbouriech N, Blackledge M, et al. Structure and dynamics of the nucleocapsid-binding domain of the Sendai virus phosphoprotein in solution. Virology 2004;319:201-211.
18. Blau DM, Compans RW. Entry and release of measles virus are polarized in epithelial cells. Virology 1995;210:91-99.
19. Blumberg BM, Leppert M, Kolakofsky D. Interaction of VSV leader RNA and nucleocapsid protein may control VSV genome replication. Cell 1981;23:837-845.
20. Bonaparte MI, Dimitrov AS, Bossart KN, et al. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc Natl Acad Sci U S A 2005;102:10652-10657.
21. Boonyaratanakornkit J, Bartlett E, Schomacker H, et al. The C proteins of human parainfluenza virus type 1 limit double-stranded RNA accumulation that would otherwise trigger activation of MDA5 and protein kinase R. J Virol 2011;85:1495-1506.
22. Bose S, Banerjee AK. Beta-catenin associates with human parainfluenza virus type 3 ribonucleoprotein complex and activates transcription of viral genome RNA in vitro. Gene Expr 2004;11:241-249.
23. Bose S, Welch BD, Kors CA, et al. Structure and mutagenesis of the parainfluenza virus 5 hemagglutinin-neuraminidase stalk domain reveals a four-helix bundle and the role of the stalk in fusion promotion. J Virol 2011;85:12855-12866.
24. Bossert B, Marozin S, Conzelmann KK. Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3. J Virol 2003;77:8661-8668.
25. Bourhis JM, Canard B, Longhi S. Structural disorder within the replicative complex of measles virus: functional implications. Virology 2006;344:94-110.
26. Bourhis JM, Receveur-Brechot V, Oglesbee M, et al. The intrinsically disordered C-terminal domain of the measles virus nucleoprotein interacts with the C-terminal domain of the phosphoprotein via two distinct sites and remains predominantly unfolded. Protein Sci 2005;14:1975-1992.
27. Bousse T, Matrosovich T, Portner A, et al. The long noncoding region of the human parainfluenza virus type 1 F gene contributes to the read-through transcription at the M-F gene junction. J Virol 2002;76:8244-8251.
28. Bousse T, Takimoto T, Gorman WL, et al. Regions on the hemagglutinin-neuraminidase proteins of human parainfluenza virus type-1 and Sendai virus important for membrane fusion. Virology 1994;204:506-514.
29. Bousse TL, Taylor G, Krishnamurthy S, et al. Biological significance of the second receptor binding site of Newcastle disease virus hemagglutinin-neuraminidase protein. J Virol 2004;78:13351-13355.
30. Bowden TA, Aricescu AR, Gilbert RJ, et al. Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2. Nat Struct Mol Biol 2008;15:567-572.
31. Bowden TA, Crispin M, Harvey DJ, et al. Dimeric architecture of the Hendra virus attachment glycoprotein: evidence for a conserved mode of assembly. J Virol 2010;84:6208-6217.
32. Bowman MC, Smallwood S, Moyer SA. Dissection of individual functions of the Sendai virus phosphoprotein in transcription. J Virol 1999;73:6474-6483.
33. Boxer EL, Nanda SK, Baron MD. The rinderpest virus non-structural C protein blocks the induction of type 1 interferon. Virology 2009;385:134-142.
34. Brown DA, London E. Structure and function of sphingolipid-and cholesterol-rich membrane rafts. J Biol Chem 2000;275:17221-17224.
35. Brown DD, Rima BK, Allen IV, et al. Rational attenuation of a morbillivirus by modulating the activity of the RNA-dependent RNA polymerase. J Virol 2005;79:14330-14338.
36. Brown G, Rixon HW, Sugrue RJ. Respiratory syncytial virus assembly occurs in GM1-rich regions of the host-cell membrane and alters the cellular distribution of tyrosine phosphorylated caveolin-1. J Gen Virol 2002;83:1841-1850.
37. Buchholz CJ, Retzler C, Homann HE, et al. The carboxy-terminal domain of Sendai virus nucleocapsid protein is involved in complex formation between phosphoprotein and nucleocapsid-like particles. Virology 1994;204:770-776.
38. Buchholz UJ, Biacchesi S, Pham QN, et al. Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicity. J Virol 2005;79:6588-6597.
39. Buchholz UJ, Finke S, Conzelmann KK. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 1999;73:251-259.
40. Bukreyev A, Whitehead SS, Murphy BR, et al. Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse. J Virol 1997;71:8973-8982.
41. Buschiazzo A, Amaya MF, Cremona ML, et al. The crystal structure and mode of action of trans-sialidase, a key enzyme in Trypanosoma cruzi pathogenesis. Mol Cell 2002;10:757-768.
42. Caffrey M, Cai M, Kaufman J, et al. Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41. EMBO J 1998;17:4572-4584.
43. Calain P, Roux L. The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J Virol 1993;67:4822-4830.
44. Calder LJ, Gonzalez-Reyes L, Garcia-Barreno B, et al. Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies. Virology 2000;271:122-131.
45. Cathomen T, Mrkic B, Spehner D, et al. A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J 1998;17:3899-3908.
46. Cathomen T, Naim HY, Cattaneo R. Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J Virol 1998;72:1224-1234.
47. Cattaneo R, Billeter MA. Mutations and A/I hypermutations in measles virus persistent infections. Curr Top Microbiol Immunol 1992;176:63-74.
48. Cattaneo R, Kaelin K, Baezko K, et al. Measles virus editing provides an additional cysteine-rich protein. Cell 1989; 56:759-764.
49. Cattaneo R, Rebmann G, Baczko K, et al. Altered ratios of measles virus transcripts in diseased human brains. Virology 1987;160:523-526.
50. Cattaneo R, Rebmann G, Schmid A, et al. Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J 1987;6:681-688.
51. Cattaneo R, Rose JK. Cell fusion by the envelope glycoproteins of persistent measles viruses which cause lethal human brain disease. J Virol 1993;67:1493-1502.
52. Cattaneo R, Schmid A, Billeter MA, et al. Multiple viral mutations rather than host factors cause defective measles virus gene expression in a subacute sclerosing panencephalitis cell line. J Virol 1988;62:1388-1397.
53. Cattaneo R, Schmid A, Eschle D, et al. Biased hypermutation and other genetic changes in defective measles virus in human brain infections. Cell 1988;55:255-265.
54. Cevik B, Holmes DE, Vrotsos E, et al. The phosphoprotein (P) and L binding sites reside in the N-terminus of the L subunit of the measles virus RNA polymerase. Virology 2004;327:297-306.
55. Chan DC, Fass D, Berger JM, et al. Core structure of gp41 from the HIV envelope glycoprotein. Cell 1997;89:263-273.
56. Chandrika R, Horikami SM, Smallwood S, et al. Mutations in conserved domain I of the Sendai virus L polymerase protein uncouple transcription and replication. Virology 1995;213:352-363.
57. Chang A, Masante C, Buchholz UJ, et al. Human metapneumovirus (HMPV) binding and infection are mediated by interactions between the HMPV fusion protein and heparan sulfate. J Virol 2012;86:3230-3243.
58. Chen L, Gorman JJ, McKimm-Breschkin J, et al. The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion. Structure 2001;9:255-266.
59. Choppin PW, Compans RW. Reproduction of paramyxoviruses. In: Fraenkel-Conrat H, Wagner RR, eds. Comprehensive Virology. Vol. 4. New York: Plenum Press; 1975:95-178.
60. Colf LA, Juo ZS, Garcia KC. Structure of the measles virus hemagglutinin. Nat Struct Mol Biol 2007;14:1227-1228.
61. Collins PL, ed. The Molecular Biology of Human Respiratory Syncytial Virus (RSV) of the Genus Pneumovirus. New York: Plenum Press; 1991.
62. Collins PL, Hill MG, Camargo E, et al. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. Proc Natl Acad Sci U S A 1995;92:11563-11567.
63. Collins PL, Hill MG, Cristina J, et al. Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus. Proc Natl Acad Sci U S A 1996;93:81-85.
64. Collins PL, Hill MG, Johnson PR. The two open reading frames of the 22K mRNA of human respiratory syncytial virus: sequence comparison of antigenic subgroups A and B and expression in vitro. J Gen Virol 1990;71:3015-3020.
65. Collins PL, Olmsted RA, Spriggs MK, et al. Gene overlap and site-specific attenuation of transcription of the viral polymerase L gene of human respiratory syncytial virus. Proc Natl Acad Sci U S A 1987;84:5134-5138.
66. Collins PL, Wertz GW. The envelope-associated 22K protein of human respiratory syncytial virus: nucleotide sequence of the mRNA and a related polytranscript. J Virol 1985;54:65-71.
67. Colman PM, Lawrence MC. The structural biology of type I viral membrane fusion. Nat Rev Mol Cell Biol 2003;4:309-319.
68. Compans RW, Mountcastle WE, Choppin PW. The sense of the helix of paramyxovirus nucleocapsids. J Mol Biol 1972;65:167-169.
69. Connolly SA, Leser GP, Jardetzky TS, et al. Bimolecular complementation of paramyxovirus fusion and hemagglutinin-neuraminidase proteins enhances fusion: implications for the mechanism of fusion triggering. J Virol 2009;83:10857-10868.
70. Conzelmann KK. Transcriptional activation of alpha/beta interferon genes: interference by nonsegmented negative-strand RNA viruses. J Virol 2005;79:5241-5248.
71. Craft WW, Jr, Dutch RE. Sequence motif upstream of the Hendra virus fusion protein cleavage site is not sufficient to promote efficient proteolytic processing. Virology 2005;341:130-140.
72. Crennell S, Takimoto T, Portner A, et al. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat Struct Biol 2000;7:1068-1074.
73. Curran J, Boeck R, Kolakofsky D. The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via mRNA editing. EMBO J 1991;10:3079-3085.
74. Curran J, Boeck R, Lin-Marq N, et al. Paramyxovirus phosphoproteins form homotrimers as determined by an epitope dilution assay, via predicted coiled coils. Virology 1995;214:139-149.
75. Curran J, de Melo M, Moyer S, et al. Characterization of the Sendai virus V protein with an anti-peptide antiserum. Virology 1991;184:108-116.
76. Curran J, Homann H, Buchholz C, et al. The hypervariable C-terminal tail of the Sendai paramyxovirus nucleocapsid protein is required for template function but not for RNA encapsidation. J Virol 1993;67:4358-4364.
77. Curran J, Kolakofsky D. Ribosomal initiation from an ACG codon in the Sendai virus P/C mRNA. EMBO J 1988;7:245-251.
78. Curran J, Marq JB, Kolakofsky D. An N-terminal domain of the Sendai paramyxovirus P protein acts as a chaperone for the NP protein during the nascent chain assembly step of genome replication. J Virol 1995;69:849-855.
79. Curran J, Marq JB, Kolakofsky D. The Sendai virus nonstructural C proteins specifically inhibit viral mRNA synthesis. Virology 1992;189:647-656.
80. Curran J, Pelet T, Kolakofsky D. An acidic activation-like domain of the Sendai virus P protein is required for RNA synthesis and encapsidation. Virology 1994;202:875-884.
81. Delenda C, Hausmann S, Garcin D, et al. Normal cellular replication of Sendai virus without the trans-frame, nonstructural V protein. Virology 1997;228:55-62.
82. Delenda C, Taylor G, Hausmann S, et al. Sendai viruses with altered P, V, and W protein expression. Virology 1998;242:327-337.
83. Demirov DG, Ono A, Orenstein JM, et al. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc Natl Acad Sci U S A 2002;99:955-960.
84. Deng R, Wang Z, Glickman RL, et al. Glycosylation within an antigenic site on the HN glycoprotein of Newcastle disease virus interferes with its role in the promotion of membrane function. Virology 1994;204:17-26.
85. Deng R, Wang Z, Mahon PJ, et al. Mutations in the Newcastle disease virus hemagglutinin-neuraminidase protein that interfere with its ability to interact with the homologous F protein in the promotion of fusion. Virology 1999;253:43-54.
86. Deng R, Wang Z, Mirza AM, et al. Localization of a domain on the paramyxovirus attachment protein required for the promotion of cellular fusion by its homologous fusion protein spike. Virology 1995;209:457-469.
87. Devaux P, von Messling V, Songsungthong W, et al. Tyrosine 110 in the measles virus phosphoprotein is required to block STAT1 phosphorylation. Virology 2007;360:72-83.
88. Didcock L, Young DF, Goodbourn S, et al. The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J Virol 1999;73:9928-9933.
89. Diederich S, Moll M, Klenk HD, et al. The Nipah virus fusion protein is cleaved within the endosomal compartment. J Biol Chem 2005;280:29899-29903.
90. Dolganiuc V, McGinnes L, Luna EJ, et al. Role of the cytoplasmic domain of the Newcastle disease virus fusion protein in association with lipid rafts. J Virol 2003;77:12968-12979.
91. Dorig RE, Marcil A, Chopra A, et al. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 1993;75:295-305.
92. Duprex WP, Collins FM, Rima BK. Modulating the function of the measles virus RNA-dependent RNA polymerase by insertion of green fluorescent protein into the open reading frame. J Virol 2002;76:7322-7328.
93. Durbin AP, Hall SL, Siew JW, et al. Recovery of infectious human parainfluenza virus type 3 from cDNA. Virology 1997;235:323-332.
94. Durbin AP, McAuliffe JM, Collins PL, et al. Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates. Virology 1999;261:319-330.
95. Durbin AP, Siew JW, Murphy BR, et al. Minimum protein requirements for transcription and RNA replication of a minigenome of human parainfluenza virus type 3 and evaluation of the rule of six. Virology 1997;234:74-83.
96. Dutch RE, Jardetzky TS, Lamb RA. Virus membrane fusion proteins: biological machines that undergo a metamorphosis. Biosci Rep 2000;20:597-612.
97. Earp LJ, Delos SE, Park HE, et al. The many mechanisms of viral membrane fusion proteins. Curr Top Microbiol Immunol 2005;285:25-66.
98. Eaton BT, Broder CC, Middleton D, et al. Hendra and Nipah viruses: different and dangerous. Nat Rev Microbiol 2006;4:23-35.
99. Ebata SN, Cote MJ, Kang CY, et al. The fusion and hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus 3 are both required for fusion. Virology 1991;183:437-441.
100. Eckert DM, Kim PS. Mechanisms of viral membrane fusion and its inhibition. Annu Rev Biochem 2001;70:777-810.
101. Egelman EH, Wu SS, Amrein M, et al. The Sendai virus nucleocapsid exists in at least four different helical states. J Virol 1989;63:2233-2243.
102. Elango N, Kovamees J, Varsanyi TM, et al. mRNA sequence and deduced amino acid sequence of the mumps virus small hydrophobic protein gene. J Virol 1989;63:1413-1415.
103. Epa VC. Modeling the paramyxovirus hemagglutinin-neuraminidase protein. Proteins 1997;29:264-281.
104. Escoffier C, Manie S, Vincent S, et al. Nonstructural C protein is required for efficient measles virus replication in human peripheral blood cells. J Virol 1999;73:1695-1698.
105. Faaberg KS, Peeples ME. Association of soluble matrix protein of Newcastle disease virus with liposomes is independent of ionic conditions. Virology 1988;166:123-132.
106. Fass D. Conformational changes in enveloped virus surface proteins during cell entry. Adv Protein Chem 2003;64:325-362.
107. Fass D, Harrison SC, Kim PS. Retrovirus envelope domain at 1.7 Å resolution. Nat Struct Biol 1996;3:465-469.
108. Fearns R, Collins PL. Model for polymerase access to the overlapped L gene of respiratory syncytial virus. J Virol 1999;73:388-397.
109. Fearns R, Collins PL. Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription. J Virol 1999;73:5852-5864.
110. Fearns R, Peeples ME, Collins PL. Increased expression of the N protein of respiratory syncytial virus stimulates minigenome replication but does not alter the balance between the synthesis of mRNA and antigenome. Virology 1997;236:188-201.
111. Feldman SA, Audet S, Beeler JA. The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate. J Virol 2000;74:6442-6447.
112. Feldman SA, Hendry RM, Beeler JA. Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G. J Virol 1999;73:6610-6617.
113. Feller JA, Smallwood S, Horikami SM, et al. Mutations in conserved domains IV and VI of the large (L) subunit of the sendai virus RNA polymerase give a spectrum of defective RNA synthesis phenotypes. Virology 2000;269:426-439.
114. Ferron F, Longhi S, Henrissat B, et al. Viral RNA-polymerases-a predicted 2'-O-ribose methyltransferase domain shared by all Mononegavirales. Trends Biochem Sci 2002;27:222-224.
115. Finch JT, Gibbs AJ. Observations on the structure of the nucleocapsids of some paramyxoviruses. J Gen Virol 1970;6:141-150.
116. Fooks AR, Stephenson JR, Warnes A, et al. Measles virus nucleocapsid protein expressed in insect cells assembles into nucleocapsid-like structures. J Gen Virol 1993;74:1439-1444.
117. Freed EO. Viral late domains. J Virol 2002;76:4679-4687.
118. Fukuhara N, Huang C, Kiyotani K, et al. Mutational analysis of the Sendai virus V protein: importance of the conserved residues for Zn binding, virus pathogenesis, and efficient RNA editing. Virology 2002;299:172-181.
119. Gainey MD, Dillon PJ, Clark KM, et al. Paramyxovirus induced shut off of translation: role of P and V proteins in limiting activation of PKR. J Virol 2008;83:828-839.
120. Galinski MS, Troy RM, Banerjee AK. RNA editing in the phosphoprotein gene of the human parainfluenza virus type 3. Virology 1992;186:543-550.
121. Garcia-Barreno B, Delgado T, Melero JA. Identification of protein regions involved in the interaction of human respiratory syncytial virus phosphoprotein and nucleoprotein: significance for nucleocapsid assembly and formation of cytoplasmic inclusions. J Virol 1996;70:801-808.
122. Garcia-Sastre A. Identification and characterization of viral antagonists of type I interferon in negative-strand RNA viruses. Curr Top Microb Immunol 2004;283:249-280.
123. Garcin D, Curran J, Itoh M, et al. Longer and shorter forms of Sendai virus C proteins play different roles in modulating the cellular antiviral response. J Virol 2001;75:6800-6807.
124. Garcin D, Itoh M, Kolakofsky D. A point mutation in the Sendai virus accessory C proteins attenuated virulence for mice, but not virus growth in cell culture. Virology 1997;238:424-431.
125. Garcin D, Marq JB, Strahle L, et al. All four Sendai virus C proteins bind Stat1, but only the larger forms also induce its mono-ubiquitination and degradation. Virology 2002;295:256-265.
126. Garcin D, Pelet T, Calain P, et al. A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus. EMBO J 1995;14:6087-6094.
127. Garrus JE, von Schwedler UK, Pornillos OW, et al. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 2001;107:55-65.
128. Giorgi C, Blumberg BM, Kolakofsky D. Sendai virus contains overlapping genes expressed from a single mRNA. Cell 1983;35:829-836.
129. Gitlin L, Benoit L, Song C, et al. Melanoma differentiation-associated gene 5 (MDA5) is involved in the innate immune response to Paramyxoviridae infection in vivo. PLoS Pathog 2010;6:e1000734.
130. Gonzalez-Reyes L, Ruiz-Arguello MB, Garcia-Barreno B, et al. Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion. Proc Natl Acad Sci U S A 2001;98:9859-9864.
131. Goodbourn S, Randall RE. The regulation of type I interferon production by paramyxoviruses. J Interferon Cytokine Res 2009;29:539-547.
132. Gotoh B, Ogasawara T, Toyoda T, et al. An endoprotease homologous to the blood clotting factor X as a determinant of viral tropism in chick embryo. EMBO J 1990;9:4189-4195.
133. Gotoh B, Takeuchi K, Komatsu T, et al. The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling. J Virol 2003;77:3360-3370.
134. Gotoh B, Yamauchi F, Ogasawara T, et al. Isolation of factor Xa from chick embryo as the amniotic endoprotease responsible for paramyxovirus activation. FEBS Lett 1992;296:274-278.
135. Gottlinger HG, Dorfman T, Sodroski JG, et al. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci U S A 1991;88:3195-3199.
136. Gravel KA, Morrison TG. Interacting domains of the HN and F proteins of Newcastle disease virus. J Virol 2003;77:11040-11049.
137. Grdzelishvili VZ, Smallwood S, Tower D, et al. A single amino acid change in the L-polymerase protein of vesicular stomatitis virus completely abolishes viral mRNA cap methylation. J Virol 2005;79:7327-7237.
138. Grogan CC, Moyer SA. Sendai virus wild-type and mutant C proteins show a direct correlation between L polymerase binding and inhibition of viral RNA synthesis. Virology 2001;288:96-108.
139. Gubbay O, Curran J, Kolakofsky D. Sendai virus genome synthesis and assembly are coupled: a possible mechanism to promote viral RNA polymerase processivity. J Gen Virol 2001;82:2895-2903.
140. Hallak LK, Spillmann D, Collins PL, et al. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J Virol 2000;74:10508-10513.
141. Hamaguchi M, Yoshida T, Nishikawa K, et al. Transcriptive complex of Newcastle disease virus. I. Both L and P proteins are required to constitute an active complex. Virology 1983;128:105-117.
142. Hardy RW, Harmon SB, Wertz GW. Diverse gene junctions of respiratory syncytial virus modulate the efficiency of transcription termination and respond differently to M2-mediated antitermination. J Virol 1999;73:170-176.
143. Hardy RW, Wertz GW. The product of the respiratory syncytial virus M2 gene ORF1 enhances readthrough of intergenic junctions during viral transcription. J Virol 1998;72:520-526.
144. Harmon SB, Wertz GW. Transcriptional termination modulated by nucleotides outside the characterized gene end sequence of respiratory syncytial virus. Virology 2002;300:304-315.
145. Harrison MS, Schmitt PT, Pei Z, et al. Role of ubiquitin in PIV5 particle formation. J Virol 2012;86:3474-3485.
146. Harty RN, Paragas J, Sudol M, et al. A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding. J Virol 1999;73:2921-2929.
147. Hasan MK, Kato A, Muranaka M, et al. Versatility of the accessory C proteins of Sendai virus: contribution to virus assembly as an additional role. J Virol 2000;74:5619-5628.
148. Hashiguchi T, Kajikawa M, Maita N, et al. Crystal structure of measles virus hemagglutinin provides insight into effective vaccines. Proc Natl Acad Sci U S A 2007;104:19535-19540.
149. Hashiguchi T, Ose T, Kubota M, et al. Structure of the measles virus hemagglutinin bound to its cellular receptor SLAM. Nat Struct Mol Biol 2011;18:135-141.
150. Hausmann S, Gardin D, Morel A-S, et al. Two nucleotides immediately upstream of the essential A6G3 slippery sequence modulate the pattern of G insertions during Sendai virus mRNA editing. J Virol 1999;73:343-351.
151. He B, Leser GP, Paterson RG, et al. The paramyxovirus SV5 small hydrophobic (SH) protein is not essential for virus growth in tissue culture cells. Virology 1998;250:30-40.
152. He B, Lin GY, Durbin JE, et al. The SH integral membrane protein of the paramyxovirus simian virus 5 is required to block apoptosis in MDBK cells. J Virol 2001;75:4068-4079.
153. He B, Paterson RG, Stock N, et al. Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: the multifunctional V protein blocks both interferon-beta induction and interferon signaling. Virology 2002;303:15-32.
154. He B, Paterson RG, Ward CD, et al. Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. Virology 1997;237:249-260.
155. Heggeness MH, Scheid A, Choppin PW. Conformation of the helical nucleocapsids of paramyxoviruses and vesicular stomatitis virus: reversible coiling and uncoiling induced by changes in salt concentration. Proc Natl Acad Sci U S A 1980;77:2631-2635.
156. Heggeness MH, Scheid A, Choppin PW. The relationship of conformational changes in the Sendai virus nucleocapsid to proteolytic cleavage of the NP polypeptide. Virology 1981;114:555-562.
157. Heggeness MH, Smith PR, Choppin PW. in vitro assembly of the nonglycosylated membrane protein (M) of Sendai virus. Proc Natl Acad Sci U S A 1982;79:6232-6236.
158. Hercyk N, Horikami SM, Moyer SA. The vesicular stomatitis virus L protein possesses the mRNA methyltransferase activities. Virology 1988;163:222-225.
159. Hiebert SW, Paterson RG, Lamb RA. Hemagglutinin-neuraminidase protein of the paramyxovirus simian virus 5: nucleotide sequence of the mRNA predicts an N-terminal membrane anchor. J Virol 1985;54:1-6.
160. Hiebert SW, Paterson RG, Lamb RA. Identification and predicted sequence of a previously unrecognized small hydrophobic protein, SH, of the paramyxovirus simian virus 5. J Virol 1985;55:744-751.
161. Hiebert SW, Richardson CD, Lamb RA. Cell surface expression and orientation in membranes of the 44-amino-acid SH protein of simian virus 5. J Virol 1988;62:2347-2357.
162. Hirano A, Ayata M, Wang AH, et al. Functional analysis of matrix proteins expressed from cloned genes of measles virus variants that cause subacute sclerosing panencephalitis reveals a common defect in nucleocapsid binding. J Virol 1993;67:1848-1853.
163. Hoffman MA, Banerjee AK. An infectious clone of human parainfluenza virus type 3. J Virol 1997;71:4272-4277.
164. Hoffman MA, Banerjee AK. Precise mapping of the replication and transcription promoters of human parainfluenza virus type 3. Virology 2000;269:201-211.
165. Holmes DE, Moyer SA. The phosphoprotein (P) binding site resides in the N terminus of the L polymerase subunit of Sendai virus. J Virol 2002;76:3078-3083.
166. Homann HE, Willenbrink W, Buchholz CJ, et al. Sendai virus protein-protein interactions studied by a protein-blotting protein-overlay technique: mapping of domains on NP protein required for binding to P protein. J Virol 1991;65:1304-1309.
167. Homma M, Ohuchi M. Trypsin action on the growth of Sendai virus in tissue culture cells. III. Structural differences of Sendai viruses grown in eggs and tissue culture cells. J Virol 1973;12:1457-1465.
168. Horikami S, Smallwood S, Moyer SA. The Sendai virus V protein interacts with the NP protein to regulate viral genome RNA replication. Virology 1996;222:383-390.
169. Horikami SM, Curran J, Kolakofsky D, et al. Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro. J Virol 1992;66:4901-4908.
170. Horikami SM, Hector RC, Smallwood S, et al. The Sendai virus C protein binds the L polymerase protein to inhibit viral RNA synthesis. Virology 1997;235:261-270.
171. Horvath CM. STAT proteins and transcriptional responses to extracellular signals. Trends Biochem Sci 2000;25:496-502.
172. Horvath CM. Weapons of STAT destruction. Interferon evasion by paramyxovirus V protein. Eur J Biochem 2004;271:4621-4628.
173. Horvath CM, Paterson RG, Shaughnessy MA, et al. Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia. J Virol 1992;66:4564-4569.
174. Horvath CM, Williams MA, Lamb RA. Eukaryotic coupled translation of tandem cistrons: identification of the influenza B virus BM2 polypeptide. EMBO J 1990;9:2639-2647.
175. Hosaka M, Nagahama M, Kim W-S, et al. Arg-X-Lys/Arg-Arg motif as a signal for precursor cleavage catalyzed by furin within the constitutive secretory pathway. J Biol Chem 1991;266:12127-12130.
176. Hu X, Ray R, Compans RW. Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses. J Virol 1992;66:1528-1534.
177. Iorio RM, Field GM, Sauvron JM, et al. Structural and functional relationship between the receptor recognition and neuraminidase activities of the Newcastle disease virus hemagglutinin-neuraminidase protein: receptor recognition is dependent on neuraminidase activity. J Virol 2001;75:1918-1927.
178. Iorio RM, Melanson VR, Mahon PJ. Glycoprotein interactions in paramyxovirus fusion. Future Virol 2009;4:335-351.
179. Irie T, Inoue M, Sakaguchi T. Significance of the YLDL motif in the M protein and Alix/AIP1 for Sendai virus budding in the context of virus infection. Virology 2010;405:334-341.
180. Irie T, Shimazu Y, Yoshida T, et al. The YLDL sequence within Sendai virus M protein is critical for budding of virus-like particles and interacts with Alix/AIP1 independently of C protein. J Virol 2007;81:2263-2273.
181. Iseni F, Baudin F, Garcin D, et al. Chemical modification of nucleotide bases and mRNA editing depend on hexamer or nucleoprotein phase in Sendai virus nucleocapsids. RNA 2002;8:1056-1067.
182. Iseni F, Garcin D, Nishio M, et al. Sendai virus trailer RNA binds TIAR, a cellular protein involved in virus-induced apoptosis. EMBO J 2002;21:5141-5150.
183. Jardetzky TS, Lamb RA. Virology: a class act. Nature 2004;427:307-308.
184. Jayakar HR, Murti KG, Whitt MA. Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release. J Virol 2000;74:9818-9827.
185. Jin H, Cheng X, Zhou HZ, et al. Respiratory syncytial virus that lacks open reading frame 2 of the M2 gene (M2-2) has altered growth characteristics and is attenuated in rodents. J Virol 2000;74:74-82.
186. Johansson K, Bourhis JM, Campanacci V, et al. Crystal structure of the measles virus phosphoprotein domain responsible for the induced folding of the C-terminal domain of the nucleoprotein. J Biol Chem 2003;278:44567-44573.
187. Joshi SB, Dutch RE, Lamb RA. A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41. Virology 1998;248:20-34.
188. Kahn JS, Schnell MJ, Buonocore L, et al. Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion. Virology 1999;254:81-91.
189. Karron RA, Buonagurio DA, Georgiu AF, et al. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. Proc Natl Acad Sci U S A 1997;94:13961-13966.
190. Kato A, Kiyotani K, Hasan MK, et al. Sendai virus gene start signals are not equivalent in reinitiation capacity: moderation at the fusion protein gene. J Virol 1999;73:9237-9246.
191. Kato A, Kiyotani K, Sakai Y, et al. Importance of the cysteine-rich carboxyl-terminal half of V protein for Sendai virus pathogenesis. J Virol 1997;71:7266-7272.
192. Kato A, Kiyotani K, Sakai Y, et al. The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J 1997;16:578-587.
193. Kato A, Ohnishi Y, Kohase M, et al. Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis. J Virol 2001;75:3802-3810.
194. Kato A, Sakai Y, Shioda T, et al. Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells 1996;1:569-579.
195. Kawai T, Takahashi K, Sato S, et al. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat Immunol 2005;6:981-988.
196. Keller MA, Parks GD. Positive-and negative-acting signals combine to determine differential RNA replication from the paramyxovirus simian virus 5 genomic and antigenomic promoters. Virology 2003;306:347-358.
197. Kikonyogo A, Bouamr F, Vana ML, et al. Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells. Proc Natl Acad Sci U S A 2001;98:11199-11204.
198. Kim YH, Donald JE, Grigoryan G, et al. Capture and imaging of a prehairpin fusion intermediate of the paramyxovirus PIV5. Proc Natl Acad Sci U S A 2011;108:20992-20997.
199. Kingsbury DW, Hsu CH, Murti KG. Intracellular metabolism of Sendai virus nucleocapsids. Virology 1978;91:86-94.
200. Kingston RL, Baase WA, Gay LS. Characterization of nucleocapsid binding by the measles virus and mumps virus phosphoproteins. J Virol 2004;78:8630-8640.
201. Klenk H-D, Garten W. Host cell proteases controlling virus pathogenicity. Trends Microbiol 1994;2:39-43.
202. Kobe B, Center RJ, Kemp BE, et al. Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins. Proc Natl Acad Sci U S A 1999;96:4319-4324.
203. Kolakofsky D, Pelet T, Garin D, et al. Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited. J Virol 1998;72:891-899.
204. Komatsu T, Takeuchi K, Yokoo J, et al. C and V proteins of Sendai virus target signaling pathways leading to IRF-3 activation for the negative regulation of interferon-beta production. Virology 2004;325:137-148.
205. Komatsu T, Takeuchi K, Yokoo J, et al. Sendai virus C protein impairs both phosphorylation and dephosphorylation processes of Stat1. FEBS Lett 2002;511:139-144.
206. Kraus TA, Garza L, Horvath CM. Enabled interferon signaling evasion in an immune-competent transgenic mouse model of parainfluenza virus 5 infection. Virology 2008;371:196-205.
207. Kuo L, Fearns R, Collins PL. Analysis of the gene start and gene end signals of human respiratory syncytial virus: quasi-templated initiation at position 1 of the encoded mRNA. J Virol 1997;71:4944-4953.
208. Kuo L, Fearns R, Collins PL. The structurally diverse intergenic regions of respiratory syncytial virus do not modulate sequential transcription by a dicistronic minigenome. J Virol 1996;70:6143-6150.
209. Kurotani A, Kiyotani K, Kato A, et al. Sendai virus C proteins are categorically nonessential gene products but silencing their expression severely impairs viral replication and pathogenesis. Genes Cells 1998;3:111-124.
210. Laliberte JP, McGinnes LW, Peeples ME, et al. Integrity of membrane lipid rafts is necessary for the ordered assembly and release of infectious Newcastle disease virus particles. J Virol 2006;80:10652-10662.
211. Lamb RA. Paramyxovirus fusion: a hypothesis for changes. Virology 1993;197:1-11.
212. Lamb RA, Choppin PW. The synthesis of Sendai virus polypeptides in infected cells. II. Intracellular distribution of polypeptides. Virology 1977;81:371-381.
213. Lamb RA, Jardetzky TS. Structural basis of viral invasion: lessons from paramyxovirus F. Curr Opin Struct Biol 2007;17:427-436.
214. Lamb RA, Mahy BW, Choppin PW. The synthesis of Sendai virus polypeptides in infected cells. Virology 1976;69:116-131.
215. Lamb RA, Paterson RG, Jardetzky TS. Paramyxovirus membrane fusion: lessons from the F and HN atomic structures. Virology 2006;344:30-37.
216. Langedijk JPM, Daus FJ, van Oirschot JT. Sequence and structure alignment of Paramyxoviridae attachment proteins and discovery of enzymatic activity for a morbillivirus hemagglutinin. J Virol 1997;71:6155-6167.
217. Latorre P, Cadd T, Itoh M, et al. The various Sendai virus C proteins are not functionally equivalent and exert both positive and negative effects on viral RNA accumulation during the course of infection. J Virol 1998;72:5984-5993.
218. Lawrence MC, Borg NA, Streltsov VA, et al. Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III. J Mol Biol 2004;335:1343-1357.
219. Lawson N, Stillman E, Whitt M, et al. Recombinant vesicular stomatitis viruses from DNA. Proc Natl Acad Sci U S A 1995;92:4477-4481.
220. Le Mercier P, Garcin D, Garcia E, et al. Competition between the Sendai virus N mRNA start site and the genome 3'-end promoter for viral RNA polymerase. J Virol 2003;77:9147-9155.
221. Le Mercier P, Garcin D, Hausmann S, et al. Ambisense Sendai viruses are inherently unstable but are useful to study viral RNA synthesis. J Virol 2002;76:5492-5502.
222. Lee B, Ataman ZA. Modes of paramyxovirus fusion: a Henipavirus perspective. Trends Microbiol 2011;19:389-399.
223. Leser GP, Lamb RA. Influenza virus assembly and budding in raft-derived microdomains: a quantitative analysis of the surface distribution of HA, NA and M2 proteins. Virology 2005;342:215-227.
224. Leyrer S, Bitzer M, Lauer U, et al. Sendai virus-like particles devoid of haemagglutinin-neuraminidase protein infect cells via the human asialoglycoprotein receptor. J Gen Virol 1998;79:683-687.
225. Li T, Chen X, Garbutt KC, et al. Structure of DDB1 in complex with a paramyxovirus V protein: viral hijack of a propeller cluster in ubiquitin ligase. Cell 2006;124:105-117.
226. Lin GY, Paterson RG, Lamb RA. The RNA binding region of the paramyxovirus SV5 V and P proteins. Virology 1997;238:460-469.
227. Lin GY, Paterson RG, Richardson CD, et al. The V protein of the paramyxovirus SV5 interacts with damage-specific DNA binding protein. Virology 1998;249:189-200.
228. Lin Y, Bright AC, Rothermel TA, et al. Induction of apoptosis by paramyxovirus simian virus 5 lacking a small hydrophobic gene. J Virol 2003;77:3371-3383.
229. Lin Y, Horvath F, Aligo JA, et al. The role of simian virus 5 V protein on viral RNA synthesis. Virology 2005;338:270-280.
230. Ling Z, Tran KC, Teng MN. Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I. J Virol 2009;83:3734-3742.
231. Liston P, Briedis DJ. Measles virus V protein binds zinc. Virology 1994;198:399-404.
232. Longhi S, Receveur-Brechot V, Karlin D, et al. The C-terminal domain of the measles virus nucleoprotein is intrinsically disordered and folds upon binding to the C-terminal moiety of the phosphoprotein. J Biol Chem. 2003;278:18638-18648.
233. Lu LL, Puri M, Horvath CM, et al. Select paramyxoviral V proteins inhibit IRF3 activation by acting as alternative substrates for inhibitor of kappaB kinase epsilon (IKKe)/TBK1. J Biol Chem 2008;283:14269-14276.
234. Mahon PJ, Mirza AM, Musich TA, et al. Engineered intermonomeric disulfide bonds in the globular domain of Newcastle disease virus hemagglutinin-neuraminidase protein: implications for the mechanism of fusion promotion. J Virol 2008;82:10386-10396.
235. Malashkevich VN, Schneider BJ, McNally ML, et al. Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution. Proc Natl Acad Sci U S A 1999;96:2662-2667.
236. Malik T, Shegogue CW, Werner K, et al. Discrimination of mumps virus small hydrophobic gene deletion effects from gene translation effects on virus virulence. J Virol 2011;85:6082-6085.
237. Malur AG, Gupta NK, De Bishnu P, et al. Analysis of the mutations in the active site of the RNA-dependent RNA polymerase of human parainfluenza virus type 3 (HPIV3). Gene Expr 2002;10:93-100.
238. Malur AG, Hoffman MA, Banerjee AK. The human parainfluenza virus type 3 (hPIV 3) C protein inhibits viral transcription. Virus Res 2004;99:199-204.
239. Manie SN, Debreyne S, Vincent S, et al. Measles virus structural components are enriched into lipid raft microdomains: a potential cellular location for virus assembly. J Virol 2000;74:305-311.
240. Manuse MJ, Briggs CM, Parks GD. Replication-independent activation of human plasmacytoid dendritic cells by the paramyxovirus SV5 requires TLR7 and autophagy pathways. Virology 2010;405:383-389.
241. Manuse MJ, Parks GD. A role for the paramyxovirus genomic promoter in limiting host cell antiviral responses and cell killing. J Virol 2009;83:9057-9067.
242. Marcos F, Ferreira L, Cros J, et al. Mapping of the RNA promoter of Newcastle disease virus. Virology 2005;331:396-406.
243. Markwell MA, Portner A, Schwartz AL. An alternative route of infection for viruses: entry by means of the asialoglycoprotein receptor of a Sendai virus mutant lacking its attachment protein. Proc Natl Acad Sci U S A 1985;82:978-982.
244. Markwell MAK. New frontiers opened by the exploration of host cell receptors. In: Kingsbury DW, ed. The Paramyxoviruses. New York: Plenum Press; 1991:407-425.
245. Markwell MAK, Fredman P, Svennerholm L. Specific gangliosides are receptors for Sendai virus. Adv Exp Biol 1984;174:369-379.
246. Markwell MAK, Moss J, Hom BE, et al. Expression of gangliosides as receptors at the cell surface controls infection of NCTC 2071 cells by Sendai virus. Virology 1986;155:356-364.
247. Martin-Serrano J, Yarovoy A, Perez-Caballero D, et al. Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins. Proc Natl Acad Sci U S A 2003;100:12414-12419.
248. Martin-Serrano J, Zang T, Bieniasz PD. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat Med 2001;7:1313-1319.
249. Mas V, Herfst S, Osterhaus AD, et al. Residues of the human metapneumovirus fusion (F) protein critical for its strain-related fusion phenotype: implications for the virus replication cycle. J Virol 2011;85:12650-12661.
250. Matsuoka Y, Curran J, Pelet T, et al. The P gene of human parainfluenza virus type 1 encodes P and C proteins but not a cysteine-rich V protein. J Virol 1991;65:3406-3410.
251. McAllister CS, Toth AM, Zhang P, et al. Mechanisms of protein kinase PKR-mediated amplification of beta interferon induction by C protein-deficient measles virus. J Virol 2010;84:380-386.
252. McGinnes L, Sergel T, Morrison T. Mutations in the transmembrane domain of the HN protein of Newcastle disease virus affect the structure and activity of the protein. Virology 1993;196:101-110.
253. McGinnes LW, Morrison TG. The role of individual oligosaccharide chains in the activities of the HN glycoprotein of Newcastle disease virus. Virology 1995;212:398-410.
254. McGinnes LW, Reitter JN, Gravel K, et al. Evidence for mixed membrane topology of the Newcastle disease virus fusion protein. J Virol 2003;77:1951-1963.
255. McLellan JS, Yang Y, Graham BS, et al. Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes. J Virol 2011;85:7788-7796.
256. Melanson VR, Iorio RM. Addition of N-glycans in the stalk of the Newcastle disease virus HN protein blocks its interaction with the F protein and prevents fusion. J Virol 2006;80:623-633.
257. Melikyan GB, Markosyan RM, Hemmati H, et al. Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. J Cell Biol 2000;151:413-423.
258. Merz DC, Prehm P, Scheid A, et al. Inhibition of the neuraminidase of paramyxoviruses by halide ions: a possible means of modulating the two activities of the HN protein. Virology 1981;112:296-305.
259. Meulendyke KA, Wurth MA, McCann RO, et al. Endocytosis plays a critical role in proteolytic processing of the Hendra virus fusion protein. J Virol 2005;79:12643-12649.
260. Mirza AM, Deng R, Iorio RM. Site-directed mutagenesis of a conserved hexapeptide in the paramyxovirus hemagglutinin-neuraminidae glycoprotein: effects on antigenic structure and function. J Virol 1994;68:5093-5099.
261. Mishin VP, Watanabe M, Taylor G, et al. N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site. J Virol 2010;84:3094-3100.
262. Moll M, Diederich S, Klenk HD, et al. Ubiquitous activation of the Nipah virus fusion protein does not require a basic amino acid at the cleavage site. J Virol 2004;78:9705-9712.
263. Moll M, Klenk HD, Maisner A. Importance of the cytoplasmic tails of the measles virus glycoproteins for fusogenic activity and the generation of recombinant measles viruses. J Virol 2002;76:7174-7186.
264. Money VA, McPhee HK, Mosely JA, et al. Surface features of a Mononegavirales matrix protein indicate sites of membrane interaction. Proc Natl Acad Sci U S A 2009;106:4441-4446.
265. Morita E, Sundquist WI. Retrovirus budding. Ann Rev Cell Dev Biol 2004;20:395-425.
266. Morrison T, McQuain C, McGinnes L. Complementation between avirulent Newcastle disease virus and a fusion protein gene expressed from a retrovirus vector: requirements for membrane fusion. J Virol 1991;65:813-822.
267. Morrison T, Portner A. 1991. Structure, function, and intracellular processing of the glycoproteins of Paramyxoviridae. In: Kingsbury DW, ed. The Paramyxoviruses. New York: Plenum Press; 1991:347-382.
268. Morrison TG. Structure and function of a paramyxovirus fusion protein. Biochim Biophys Acta 2003;1614:73-84.
269. Moyer SA, Baker SC, Horikami SM. Host cell proteins required for measles virus reproduction. J Gen Virol 1990;71:775-783.
270. Muhlebach MD, Mateo M, Sinn PL, et al. Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature 2011;480:530-533.
271. Murphy LB, Loney C, Murray J, et al. Investigations into the amino-terminal domain of the respiratory syncytial virus nucleocapsid protein reveal elements important for nucleocapsid formation and interaction with the phosphoprotein. Virology 2003;307:143-153.
272. Murphy SK, Ito Y, Parks GD. A functional antigenomic promoter for the paramyxovirus simian virus 5 requires proper spacing between an essential internal segment and the 3' terminus. J Virol 1998;72:10-19.
273. Murphy SK, Parks GD. Genome nucleotide lengths that are divisible by six are not essential but enhance replication of defective interfering RNAs of the paramyxovirus simian virus 5. Virology 1997;232:145-157.
274. Murphy SK, Parks GD. RNA replication for the paramyxovirus simian virus 5 requires an internal repeated (CGNNNN) sequence motif. J Virol 1999;73:805-809.
275. Murrell MT, Porotto M, Greengard O, et al. A single amino acid alteration in the human parainfluenza virus type 3 hemagglutinin-neuraminidase glycoprotein confers resistance to the inhibitory effects of zanamivir on receptor binding and neuraminidase activity. J Virol 2001;75:6310-6320.
276. Myers TM, Moyer SA. An amino-terminal domain of the Sendai virus nucleocapsid protein is required for template function in viral RNA synthesis. J Virol 1997;71:918-924.
277. Myers TM, Pieters A, Moyer SA. A highly conserved region of the Sendai virus nucleocapsid protein contributes to the NP-NP binding domain. Virology 1997;229:322-335.
278. Nagai Y, Klenk H-D. Activation of precursors to both glycoproteins of Newcastle disease virus by proteolytic cleavage. Virology 1977;77:125-134.
279. Nagai Y, Klenk HD, Rott R. Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology 1976;72:494-508.
280. Nagai Y, Ogura H, Klenk H-D. Studies on the assembly of the envelope of Newcastle disease virus. Virology 1976;69:523-538.
281. Nakatsu Y, Takeda M, Ohno S, et al. Measles virus circumvents the host interferon response by different actions of the C and V proteins. J Virol 2008;82:8296-8306.
282. Naniche D, Varior-Krishnan G, Cervoni F, et al. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 1993;67:6025-6032.
283. Navaratnarajah CK, Oezguen N, Rupp L, et al. The heads of the measles virus attachment protein move to transmit the fusion-triggering signal. Nat Struct Mol Biol 2011;18:128-134.
284. Negrete OA, Levroney EL, Aguilar HC, et al. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature 2005;436:401-405.
285. Ng DT, Hiebert SW, Lamb RA. Different roles of individual N-linked oligosaccharide chains in folding, assembly, and transport of the simian virus 5 hemagglutinin-neuraminidase. Mol Cell Biol 1990;10:1989-2001.
286. Ng DT, Randall RE, Lamb RA. Intracellular maturation and transport of the SV5 type II glycoprotein hemagglutinin-neuraminidase: specific and transient association with GRP78-BiP in the endoplasmic reticulum and extensive internalization from the cell surface. J Cell Biol 1989;109:3273-3289.
287. Nishio M, Tsurudome M, Ito M, et al. Mapping of domains on the human parainfluenza virus type 2 nucleocapsid protein (NP) required for NP-phosphoprotein or NP-NP interaction. J Gen Virol 1999;80:2017-2022.
288. Noyce RS, Bondre DG, Ha MN, et al. Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog 2011;7:e1002240.
289. Ogino T, Kobayashi M, Iwama M, et al. Sendai virus RNA-dependent RNA polymerase L protein catalyzes cap methylation of virus-specific mRNA. J Biol Chem 2005;280:4429-4435.
290. Ohno S, Ono N, Takeda M, et al. Dissection of measles virus V protein in relation to its ability to block alpha/beta interferon signal transduction. J Gen Virol 2004;85:2991-2999.
291. Oldstone MBA, Homann D, Lewicki H, et al. One, two, or three step: measles virus receptor dance. Virology 2002;299:162-163.
292. Olmsted RA, Collins PL. The 1A protein of respiratory syncytial virus is an integral membrane protein present as multiple, structurally distinct species. J Virol 1989;63:2019-2029.
293. Olmsted RA, Elango N, Prince GA, et al. Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proc Natl Acad Sci U S A 1986;83:7462-7466.
294. Ortmann D, Ohuchi M, Angliker H, et al. Proteolytic cleavage of wild type and mutants of the F protein of human parainfluenza virus type 3 by two subtilisin-like endoproteases, furin and KEX2. J Virol 1994;68:2772-2776.
295. Paal T, Brindley MA, St Clair C, et al. Probing the spatial organization of measles virus fusion complexes. J Virol 2009;83:10480-10493.
296. Pager CT, Dutch RE. Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein. J Virol 2005;79:12714-12720.
297. Palosaari H, Parisien JP, Rodriguez JJ, et al. STAT protein interference and suppression of cytokine signal transduction by measles virus V protein. J Virol 2003;77:7635-7644.
298. Parisien JP, Lau JF, Horvath CM. STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replication. J Virol 2002;76:6435-6441.
299. Park MS, Garcia-Sastre A, Cros JF, et al. Newcastle disease virus V protein is a determinant of host range restriction. J Virol 2003;77:9522-9532.
300. Parks CL, Witko SE, Kotash C, et al. Role of V protein RNA binding in inhibition of measles virus minigenome replication. Virology 2006;348:96-106.
301. Parks GD, Lamb RA. Folding and oligomerization properties of a soluble and secreted form of the paramyxovirus hemagglutinin-neuraminidase glycoprotein. Virology 1990;178:498-508.
302. Paterson RG, Hiebert SW, Lamb RA. Expression at the cell surface of biologically active fusion and hemagglutinin-neuraminidase proteins of the paramyxovirus simian virus 5 from cloned cDNA. Proc Natl Acad Sci U S A 1985;82:7520-7524.
303. Paterson RG, Lamb RA. RNA editing by G-nucleotide insertion in mumps virus P-gene mRNA transcripts. J Virol 1990;64:4137-4145.
304. Paterson RG, Leser GP, Shaughnessy MA, et al. The paramyxovirus SV5 V protein binds two atoms of zinc and is a structural component of virions. Virology 1995;208:121-131.
305. Paterson RG, Russell CJ, Lamb RA. Fusion protein of the paramyxovirus SV5: destabilizing and stabilizing mutants of fusion activation. Virology 2000;270:17-30.
306. Paterson RG, Shaughnessy MA, Lamb RA. Analysis of the relationship between cleavability of a paramyxovirus fusion protein and length of the connecting peptide. J Virol 1989;63:1293-1301.
307. Paterson RG, Thomas SM, Lamb RA. Specific nontemplated nucleotide addition to a simian virus 5 mRNA: prediction of a common mechanism by which unrecognized hybrid P-cysteine-rich proteins are encoded by paramyxovirus "P" genes. In: Kolakofsky D, Mahy BWJ, eds. Genetics and Pathogenicity of Negative Strand Viruses. London: Elsevier; 1989:232-245.
308. Patnaik A, Chau V, Wills JW. Ubiquitin is part of the retrovirus budding machinery. Proc Natl Acad Sci U S A 2000;97:13069-13074.
309. Patterson JB, Cornu TI, Redwine J, et al. Evidence that the hypermutated M protein of a subacute sclerosing panencephalitis measles virus actively contributes to the chronic progressive CNS disease. Virology 2001;291:215-225.
310. Patterson JB, Thomas D, Lewicki H, et al. V and C proteins of measles virus function as virulence factors in vivo. Virology 2000;267:80-89.
311. Peeples ME. Paramyxovirus M proteins: pulling it all together and taking it on the road. In: Kingsbury DW, ed. The Paramyxoviruses. New York: Plenum Press; 1991:427-456.
312. Peeters BP, de Leeuw OS, Koch G, et al. Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J Virol 1999;73:5001-5009.
313. Pei Z, Bai Y, Schmitt AP. PIV5 M protein interaction with host protein angiomotin-like 1. Virology 2010;397:155-166.
314. Pei Z, Harrison MS, Schmitt AP. Parainfluenza virus 5 M protein interaction with host protein 14-3-3 negatively affects virus particle formation. J Virol 2011;85:2050-2059.
315. Pelet T, Delenda C, Gubbay O, et al. Partial characterization of a Sendai virus replication promoter and the rule of six. Virology 1996;224:405-414.
316. Pennington TH, Pringle CR. Negative strand viruses in enucleate cells. In Mahy BWJ, Barry RD, eds. Negative Strand Viruses and the Host Cell. New York: Academic Press; 1978:457-464.
317. Pfaller CK, Conzelmann KK. Measles virus V protein is a decoy substrate for IkappaB kinase alpha and prevents toll-like receptor 7/9-mediated interferon induction. J Virol 2008;82:12365-12373.
318. Plemper RK, Brindley MA, Iorio RM. Structural and mechanistic studies of measles virus illuminate paramyxovirus entry. PLoS Pathog 2011;7:e1002058.
319. Poch O, Blumberg BM, Bougueleret L, et al. Sequence comparison of five polymerases (L proteins) of unsegmented negative-strand RNA viruses: theoretical assignment of functional domains. J Gen Virol 1990;71:1153-1162.
320. Poole EL, He B, Lamb RA, et al. The V proteins of simian virus 5 and other paramyxoviruses inhibits induction of interferon-beta. Virology 2002;303:33-46.
321. Popa A, Carter JR, Smith SE, et al. Residues in the Hendra virus fusion protein transmembrane domain are critical for endocytic recycling. J Virol 2012;86:3014-3026.
322. Porotto M, Devito I, Palmer SG, et al. Spring-loaded model revisited: paramyxovirus fusion requires engagement of a receptor binding protein beyond initial triggering of the fusion protein. J Virol 2011;85:12867-12880.
323. Porotto M, Fornabaio M, Greengard O, et al. Paramyxovirus receptor-binding molecules: engagement of one site on the hemagglutinin-neuraminidase protein modulates activity at the second site. J Virol 2006;80:1204-1213.
324. Porotto M, Murrell M, Greengard O, et al. Triggering of human parainfluenza virus 3 fusion protein (F) by the hemagglutinin-neuraminidase (HN) protein: an HN mutation diminishes the rate of F activation and fusion. J Virol 2003;77:3647-3654.
325. Porotto M, Palmer SG, Palermo LM, et al. Mechanism of fusion triggering by human parainfluenza virus type III: communication between viral glycoproteins during entry. J Biol Chem 2012;287:778-793.
326. Portner A, Marx PA, Kingsbury DW. Isolation and characterization of Sendai virus temperature-sensitive mutants. J Virol 1974;13:298-304.
327. Portner A, Murti KG, Morgan EM, et al. Antibodies against Sendai virus L protein: distribution of the protein in nucleocapsids revealed by immunoelectron microscopy. Virology 1988;163:236-239.
328. Portner A, Scroggs RA, Marx PS, et al. A temperature-sensitive mutant of Sendai virus with an altered hemagglutinin-neuraminidase polypeptide: consequences for virus assembly and cytopathology. Virology 1975;67:179-187.
329. Portner A, Scroggs RA, Metzger DW. Distinct functions of antigenic sites of the HN glycoprotein of Sendai virus. Virology 1987;158:61-68.
330. Precious B, Childs K, Fitzpatrick-Swallow V, et al. Simian virus 5 V protein acts as an adaptor, linking DDB1 to STAT2, to facilitate the ubiquitination of STAT1. J Virol 2005;79:13434-13441.
331. Precious B, Young DF, Bermingham A, et al. Inducible expression of the P, V, and NP genes of the paramyxovirus simian virus 5 in cell lines and an examination of NP-P and NP-V interactions. J Virol 1995;69:8001-8010.
332. Radecke F, Spielhofer P, Schneider H, et al. Rescue of measles viruses from cloned DNA. EMBO J 1995;14:5773-5784.
333. Rassa JC, Parks GD. Highly diverse intergenic regions of the paramyxovirus simian virus 5 cooperate with the gene end U tract in viral transcription termination and can influence reinitiation at a downstream gene. J Virol 1999;73:3904-3912.
334. Rassa JC, Parks GD. Molecular basis for naturally occurring elevated readthrough transcription across the M-F junction of the paramyxovirus SV5. Virology 1998;247:274-286.
335. Roberts A, Rose JK. Recovery of negative-strand RNA viruses from plasmid DNAs: a positive approach revitalizes a negative field. Virology 1998;247:1-6.
336. Rodriguez JJ, Cruz CD, Horvath CM. Identification of the nuclear export signal and STAT-binding domains of the Nipah virus V protein reveals mechanisms underlying interferon evasion. J Virol 2004;78:5358-5367.
337. Rodriguez JJ, Wang LF, Horvath CM. Hendra virus V protein inhibits interferon signaling by preventing STAT1 and STAT2 nuclear accumulation. J Virol 2003;77:11842-11845.
338. Rodriguez-Boulan E, Sabatini DD. Asymmetric budding of viruses in epithelial monolayers; a model system for study of epithelial polarity. Proc Natl Acad Sci U S A 1978;75:5071-5075.
339. Rossman JS, Jing X, Leser GP, et al. Influenza virus M2 ion channel protein is necessary for filamentous virion formation. J Virol 2010;84:5078-5088.
340. Rossman JS, Jing X, Leser GP, et al. Influenza virus M2 protein mediates ESCRT-independent membrane scission. Cell 2010;142:902-913.
341. Roux L, Waldvogel FA. Instability of the viral M protein in BHK-21 cells persistently infected with Sendai virus. Cell 1982;28:293-302.
342. Ruiz-Arguello MB, Gonzalez-Reyes L, Calder LJ, et al. Effect of proteolytic processing at two distinct sites on shape and aggregation of an anchorless fusion protein of human respiratory syncytial virus and fate of the intervening segment. Virology 2002;298:317-326.
343. Ruiz-Arguello MB, Martin D, Wharton SA, et al. Thermostability of the human respiratory syncytial virus fusion protein before and after activation: implications for the membrane-fusion mechanism. J Gen Virol 2004;85:3677-3687.
344. Russell CJ, Jardetzky TS, Lamb RA. Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion. EMBO J 2001;20:4024-4034.
345. Russell CJ, Kantor KL, Jardetzky TS, et al. A dual-functional paramyxovirus F protein regulatory switch segment: activation and membrane fusion. J Cell Biol 2003;163:363-374.
346. Russell R, Paterson RG, Lamb RA. Studies with cross-linking reagents on the oligomeric form of the paramyxovirus fusion protein. Virology 1994;199:160-168.
347. Sakaguchi T, Kato A, Sugahara F, et al. AIP1/Alix is a binding partner of Sendai virus C protein and facilitates virus budding. J Virol 2005;79:8933-8941.
348. Sakaguchi T, Kiyotani K, Kato A, et al. Phosphorylation of the Sendai virus M protein is not essential for virus replication either in vitro or in vivo. Virology 1997;235:360-366.
349. Sakai Y, Shibuta H. Syncytium formation by recombinant vaccinia viruses carrying bovine parainfluenza 3 virus envelope protein genes. J Virol 1989;63:3661-3668.
350. Samal SK, Collins PL. RNA replication by a respiratory syncytial virus RNA analog does not obey the rule of six and retains a nonviral trinucleotide extension at the leader end. J Virol 1996;70:5075-5082.
351. Sanderson CM, Avalos R, Kundu A, et al. Interaction of Sendai viral F, HN, and M proteins with host cytoskeletal and lipid components in Sendai virus-infected BHK cells. Virology 1995;209:701-707.
352. Satake M, Coligan JE, Elango N, et al. Respiratory syncytial virus envelope glycoprotein (G) has a novel structure. Nucleic Acids Res 1985;13:7795-7812.
353. Scheid A, Caliguiri LA, Compans RW, et al. Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein. Virology 1972;50:640-652.
354. Scheid A, Choppin PW. Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus. Virology 1974;57:475-490.
355. Scheid A, Choppin PW. The hemagglutinating and neuraminidase protein of a paramyxovirus: interaction with neuraminic acid in affinity chromatography. Virology 1974;62:125-133.
356. Schlender J, Hornung V, Finke S, et al. Inhibition of toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus. J Virol 2005;79:5507-5515.
357. Schmitt AP, He B, Lamb RA. Involvement of the cytoplasmic domain of the hemagglutinin-neuraminidase protein in assembly of the paramyxovirus simian virus 5. J Virol 1999;73:8703-8712.
358. Schmitt AP, Leser GP, Morita E, et al. Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus. J Virol 2005;79:2988-2997.
359. Schmitt AP, Leser GP, Waning DL, et al. Requirements for budding of paramyxovirus simian virus 5 virus-like particles. J Virol 2002;76:3952-3964.
360. Schneider H, Kaelin K, Billeter MA. Recombinant measles viruses defective for RNA editing and V protein synthesis are viable in cultured cells. Virology 1997;227:314-322.
361. Schnell MJ, Mebatsion T, Conzelmann K-K. Infectious rabies viruses from cloned cDNA. EMBO J 1994;13:4195-4203.
362. Schowalter RM, Chang A, Robach JG, et al. Low-pH triggering of human metapneumovirus fusion: essential residues and importance in entry. J Virol 2009;83:1511-1522.
363. Schubert U, Ott DE, Chertova EN, et al. Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc Natl Acad Sci U S A 2000;97:13057-13062.
364. Schuhmann KM, Pfaller CK, Conzelmann KK. The measles virus V protein binds to p65 (RelA) to suppress NF-kappaB activity. J Virol 2011;85:3162-3171.
365. Sergel R, McGinnes LW, Morrison TG. The fusion promotion activity of the NDV HN protein does not correlate with neuraminidase activity. Virology 1993;196:831-834.
366. Sergel T, McGinnes LW, Peeples ME, et al. The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation. Virology 1993;193:717-726.
367. Sergel TA, McGinnes LW, Morrison TG. A single amino acid change in the Newcastle disease virus fusion protein alters the requirement for HN protein in fusion. J Virol 2000;74:5101-5107.
368. Shaffer JA, Bellini WJ, Rota PA. The C protein of measles virus inhibits the type I interferon response. Virology 2003;315:389-397.
369. Shaikh FY, Cox RG, Lifland AW, et al. A critical phenylalanine residue in the respiratory syncytial virus fusion protein cytoplasmic tail mediates assembly of internal viral proteins into viral filaments and particles. MBio 2012;3:e00270-00211.
370. Shaw ML, Cardenas WB, Zamarin D, et al. Nuclear localization of the Nipah virus W protein allows for inhibition of both virus-and toll-like receptor 3-triggered signaling pathways. J Virol 2005;79:6078-6088.
371. Shaw ML, Garcia-Sastre A, Palese P, et al. Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively. J Virol 2004;78:5633-5641.
372. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997;387:569-572.
373. Skehel JJ, Wiley DC. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 2000;69:531-569.
374. Skibbens JE, Roth MG, Matlin KS. Differential extractability of influenza virus hemagglutinin during intracellular transport in polarized epithelial cells and nonpolar fibroblasts. J Cell Biol 1989;108:821-832.
375. Sleeman K, Baron MD. The polymerase (L) protein of rinderpest virus interacts with the host cell protein striatin. Virology 2005;332:225-234.
376. Smallwood S, Cevik B, Moyer SA. Intragenic complementation and oligomerization of the L subunit of the Sendai virus RNA polymerase. Virology 2002;304:235-245.
377. Spann KM, Tran KC, Chi B, et al. Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages. J Virol 2004;78:4363-4369.
378. Sparrer KM, Pfaller CK, Conzelmann KK. Measles virus C protein interferes with Beta interferon transcription in the nucleus. J Virol 2012;86:796-805.
379. Spehner D, Drillien R, Howley PM. The assembly of the measles virus nucleoprotein into nucleocapsid-like particles is modulated by the phosphoprotein. Virology 1997;232:260-268.
380. Spriggs MK, Collins PL. Human parainfluenza virus type 3: messenger RNAs, polypeptide coding assignments, intergenic sequences, and genetic map. J Virol 1986;59:646-654.
381. Stone-Hulslander J, Morrison TG. Detection of an interaction between the HN and F proteins in Newcastle disease virus-infected cells. J Virol 1997;71:6287-6295.
382. Stone-Hulslander J, Morrison TG. Mutational analysis of heptad repeats in the membrane-proximal region of Newcastle disease virus HN protein. J Virol 1999;73:3630-3637.
383. Strack B, Calistri A, Accola MA, et al. A role for ubiquitin ligase recruitment in retrovirus release. Proc Natl Acad Sci U S A 2000;97:13063-13068.
384. Strack B, Calistri A, Craig S, et al. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 2003;114:689-699.
385. Strahle L, Marq JB, Brini A, et al. Activation of the beta interferon promoter by unnatural Sendai virus infection requires RIG-I and is inhibited by viral C proteins. J Virol 2007;81:12227-12237.
386. Stricker R, Mottet G, Roux L. The Sendai virus matrix protein appears to be recruited in the cytoplasm by the viral nucleocapsid to function in viral assembly and budding. J Gen Virol 1994;75:1031-1042.
387. Stricker R, Roux L. The major glycoprotein of Sendai virus is dispensable for efficient virus particle budding. J Gen Virol 1991;72:1703-1707.
388. Swanson K, Wen X, Leser GP, et al. Structure of the Newcastle disease virus F protein in the post-fusion conformation. Virology 2010;402:372-379.
389. Swanson KA, Settembre EC, Shaw CA, et al. Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers. Proc Natl Acad Sci U S A 2011;108:9619-9624.
390. Sweetman DA, Miskin J, Baron MD. Rinderpest virus C and V proteins interact with the major (L) component of the viral polymerase. Virology 2001;281:193-204.
391. Takeuchi K, Komatsu T, Kitagawa Y, et al. Sendai virus C protein plays a role in restricting PKR activation by limiting the generation of intracellular double-stranded RNA. J Virol 2008;82:10102-10110.
392. Takeuchi K, Komatsu T, Yokoo J, et al. Sendai virus C protein physically associates with Stat1. Genes Cells 2001;6:545-557.
393. Takeuchi K, Tanabayashi K, Hishiyama M, et al. The mumps virus SH protein is a membrane protein and not essential for virus growth. Virology 1996;225:156-162.
394. Takeuchi K, Tanabayashi K, Hishiyama M, et al. Variation of nucleotide sequences and transcription of the SH gene among mumps virus strains. Virology 1991;181:364-366.
395. Takimoto T, Murti KG, Bousse T, et al. Role of matrix and fusion proteins in budding of Sendai virus. J Virol 2001;75:11384-11391.
396. Tan K, Liu J-H, Wang J-H, et al. Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc Natl Acad Sci U S A 1997;94:12303-12308.
397. Tanabayashi K, Compans RW. Functional interaction of paramyxovirus glycoproteins: identification of a domain in Sendai virus HN which promotes cell fusion. J Virol 1996;70:6112-6118.
398. Taniguchi T, Palmieri M, Weissmann C. Qβ DNA-containing hybrid plasmids giving rise to Qβ phage formation in the bacterial host. Nature 1978;274:223-228.
399. Tapparel C, Hausmann S, Pelet T, et al. Inhibition of Sendai virus genome replication due to promoter-increased selectivity: a possible role for the accessory C proteins. J Virol 1997;71:9588-9599.
400. Tapparel C, Maurice D, Roux L. The activity of Sendai virus genomic and antigenomic promoters requires a second element past the leader template regions: a motif (GNNNNN)3 is essential for replication. J Virol 1998;72:3117-3128.
401. Tapparel C, Roux L. The efficiency of Sendai virus genome replication: the importance of the RNA primary sequence independent of terminal complementarity. Virology 1996;225:163-171.
402. Tarbouriech N, Curran J, Ebel C, et al. On the domain structure and the polymerization state of the sendai virus P protein. Virology 2000;266:99-109.
403. Tashiro M, Yamakawa M, Tobita K, et al. Altered budding site of a pantropic mutant of Sendai virus, F1-R, in polarized epithelial cells. J Virol 1990;64:4672-4677.
404. Tatsuo H, Ono N, Tanaka K, et al. SLAM (CDw150) is a cellular receptor for measles virus. Nature 2000;406:893-897.
405. Taylor G. Sialidases: structures, biological significance and therapeutic potential. Curr Opin Struct Biol 1996;6:830-837.
406. Techaarpornkul S, Collins PL, Peeples ME. Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus. Virology 2002;294:296-304.
407. Teng MN, Collins PL. Altered growth characteristics of recombinant respiratory syncytial viruses which do not produce NS2 protein. J Virol 1999;73:466-473.
408. Thomas SM, Lamb RA, Paterson RG. Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5. Cell 1988;54:891-902.
409. Thompson SD, Laver WG, Murti KG, et al. Isolation of a biologically active soluble form of the hemagglutinin-neuraminidase protein of Sendai virus. J Virol 1988;62:4653-4660.
410. Thompson SD, Portner A. Localization of functional sites on the hemagglutinin-neuraminidase glycoprotein of Sendai virus by sequence analysis of antigenic and temperature-sensitive mutants. Virology 1987;160:1-8.
411. Timmins J, Schoehn G, Ricard-Blum S, et al. Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4. J Mol Biol 2003;326:493-502.
412. Tober C, Seufert M, Schneider H, et al. Expression of measles virus V protein is associated with pathogenicity and control of viral RNA synthesis. J Virol 1998;72:8124-8132.
413. Tsurudome M, Bando H, Kawano M, et al. Transcripts of simian virus 41 (SV41) matrix gene are exclusively dicistronic with the fusion gene which is also transcribed as a monocistron. Virology 1991;184:93-100.
414. Tsurodome M, Kawano M, Yuasa T, et al. Identification of regions on the hemagglutinin-neuraminidase protein of human parainfluenza virus type 2 important for promoting cell fusion. Virology 1995;213:190-203.
415. Tuffereau C, Portner A, Roux L. The role of haemagglutinin-neuraminidase glycoprotein cell surface expression in the survival of Sendai virus-infected BHK-21 cells. J Gen Virol 1985;66:2313-2318.
416. Ulane CM, Horvath CM. Paramyxoviruses SV5 and HPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components. Virology 2002;304:160-166.
417. Ulane CM, Kentsis A, Cruz CD, et al. Composition and assembly of STAT-targeting ubiquitin ligase complexes: paramyxovirus V protein carboxyl terminus is an oligomerization domain. J Virol 2005;79:10180-10189.
418. Valsamakis A, Schneider H, Auwaerter PG, et al. Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo. J Virol 1998;72:7754-7761.
419. Vidal S, Curran J, Kolakofsky D. Editing of the Sendai virus P/C mRNA by G insertion occurs during mRNA synthesis via a virus-encoded activity. J Virol 1990;64:239-246.
420. Vidal S, Kolakofsky D. Modified model for the switch from Sendai virus transcription to replication. J Virol 1989;63:1951-1958.
421. Vincent O, Rainbow L, Tilburn J, et al. YPXL/I is a protein interaction motif recognized by aspergillus PalA and its human homologue, AIP1/Alix. Mol Cell Biol 2003;23:1647-1655.
422. Vincent S, Gerlier D, Manie SN. Measles virus assembly within membrane rafts. J Virol 2000;74:9911-9915.
423. Vogt VM. Ubiquitin in retrovirus assembly: actor or bystander? Proc Natl Acad Sci U S A 2000;97:12945-12947.
424. Von Schwedler UK, Stuchell M, Muller B, et al. The protein network of HIV budding. Cell 2003;114:701-713.
425. Vulliemoz D, Roux L. "Rule of six": how does the Sendai virus RNA polymerase keep count? J Virol 2001;75:4506-4518.
426. Walpita P. An internal element of the measles virus antigenome promoter modulates replication efficiency. Virus Res 2004;100:199-211.
427. Wang LF, Michalski WP, Yu M, et al. A novel P/V/C gene in a new member of the Paramyxoviridae family, which causes lethal infection in humans, horses, and other animals. J Virol 1998;72:1482-1490.
428. Waning DL, Russell CJ, Jardetzky TS, et al. Activation of a paramyxovirus fusion protein is modulated by inside-out signaling from the cytoplasmic tail. Proc Natl Acad Sci U S A 2004;101:9217-9222.
429. Waning DL, Schmitt AP, Leser GP, et al. Roles for the cytoplasmic tails of the fusion and hemagglutinin-neuraminidase proteins in budding of the paramyxovirus simian virus 5. J Virol 2002;76:9284-9297.
430. Wansley EK, Parks GD. Naturally occurring substitutions in the P/V gene convert the noncytopathic paramyxovirus simian virus 5 into a virus that induces alpha/beta interferon synthesis and cell death. J Virol 2002;76:10109-10121.
431. Wardrop EA, Briedis DJ. Characterization of V protein in measles virus-infected cells. J Virol 1991;65:3421-3428.
432. Weissenhorn W, Calder LJ, Dessen A, et al. Assembly of a rod-shaped chimera of a trimeric GCN4 zipper and the HIV-1 gp41 ectodomain expressed in Escherichia coli. Proc Natl Acad Sci U S A 1997;94:6065-6069.
433. Weissenhorn W, Carfi A, Lee K-H, et al. Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol Cell 1998;2:605-616.
434. Weissmann C. Reversed genetics. A new approach to the elucidation of structure-function relationships. Trends Biochem Sci 1978;3:N109-N111.
435. Wertz GW, Collins PL, Huang Y, et al. Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein. Proc Natl Acad Sci U S A 1985;82:4075-4079.
436. Whelan SP, Ball LA, Barr JN, et al. Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc Natl Acad Sci U S A 1995;92:8388-8392.
437. Whitehead SS, Bukreyev A, Teng MN, et al. Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees. J Virol 1999;73:3438-3442.
438. Wild TF, Malvoisin E, Buckland R. Measles virus: both the haemagglutinin and fusion glycoproteins are required for fusion. J Gen Virol 1991;72:439-442.
439. Wilson RL, Fuentes SM, Wang P, et al. Function of small hydrophobic proteins of paramyxovirus. J Virol 2006;80:1700-1709.
440. Wong TC, Ayata M, Ueda S, et al. Role of biased hypermutation in evolution of subacute sclerosing panencephalitis virus from progenitor acute measles virus. J Virol 1991;65:2191-2199.
441. Xu K, Rajashankar KR, Chan YP, et al. Host cell recognition by the Henipaviruses: crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3. Proc Natl Acad Sci U S A 2008;105:9953-9958.
442. Yanagi Y, Ono N, Tatsuo H, et al. Measles virus receptor SLAM (CD150). Virology 2002;299:155-161.
443. Yao Q, Hu X, Compans RW. Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces. J Virol 1997;71:650-656.
444. Yin H-S, Paterson RG, Wen X, et al. Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein. Proc Natl Acad Sci U S A 2005;102:9288-9293.
445. Yin HS, Wen X, Paterson RG, et al. Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature 2006;439:38-44.
446. Yoneyama M, Kikuchi M, Natsukawa T, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004;5:730-737.
447. Young DF, Chatziandreou N, He B, et al. Single amino acid substitution in the V protein of simian virus 5 differentiates its ability to block interferon signaling in human and murine cells. J Virol 2001;75:3363-3370.
448. Young DF, Didcock L, Goodbourn S, et al. Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response. Virology 2000;269:383-390.
449. Young JK, Hicks RP, Wright GE, et al. Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling. Virology 1997;238:291-304.
450. Yuan P, Swanson KA, Leser GP, et al. Structure of the Newcastle disease virus hemagglutinin-neuraminidase (HN) ectodomain reveals a four-helix bundle stalk. Proc Natl Acad Sci U S A 2011;108:14920-14925.
451. Yuan P, Thompson T, Wurzburg BA, et al. Structural studies of the parainfluenza virius 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose. Structure 2005;13:1-13.
452. Yuasa T, Kawano M, Tabata N, et al. A cell fusion-inhibiting monoclonal antibody binds to the presumed stalk domain of the human parainfluenza type 2 virus hemagglutinin-neuraminidase protein. Virology 1995;206:1117-1125.
453. Zaitsev V, Von Itzsteine M, Groves D, et al. Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications in fusion. J Virol 2004;78:3733-3741.
454. Zhang J, Pekosz A, Lamb RA. Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins. J Virol 2000;74:4634-4644.
455. Zhang X, Bourhis JM, Longhi S, et al. Hsp72 recognizes a P binding motif in the measles virus N protein C-terminus. Virology 2005;337:162-174.
456. Zhao X, Singh M, Malashkevich VN, et al. Structural characterization of the human respiratory syncytial virus fusion protein core. Proc Natl Acad Sci U S A 2000;97:14172-14177.
457. Zimmer G, Budz L, Herrler G. Proteolytic activation of respiratory syncytial virus fusion protein. Cleavage at two furin consensus sequences. J Biol Chem 2001;276:31642-31650.